New PRA Toolkit Helps Researchers Identify Risks in Clinical Trials
Researchers of rare and orphan diseases face unique challenges when it comes to drug development. Enrolling in a clinical trial [...]
ISPOR Awards Council Accepting Nominations, Announces New HEOR Excellence Award
The ISPOR Awards Council is taking nominations for its annual awards. It has also announced a new award, the LMIC [...]
ICER Adds Members to Three Appraisal Councils to Boost Evidence Reviews
ICER (the Institute for Clinical and Economic Review) has added members to three independence appraisal councils: Midwest CEPAC (Midwest Comparative [...]
Panacea and IQVIA Host RWE and HEOR Webinar on Saturday, March 20th
A webinar on RWE (real world evidence) and HEOR (health economics and outcomes research) will take place on March 20th [...]
Syneos Health Communications Adds Three Senior Hires to Team
Syneos has added three high-profile hires to their team. Orrin Pollard will take on the role of Director of European [...]
ICER Unsatisfied With Fibrogen’s Roxadustat Evidence; FDA Calls Advisory Committee
ICER held a meeting on February 11th, during which its independent appraisal committee agreed that it was not possible to [...]
Understanding the Spectrum of Low-Value Care and Economic Implications
In a recent study, researchers compared over one thousand low-value care recommendations from five US healthcare organizations (USPSTF, ACP, ACC/AHA, [...]
How Will Emphasis on Patient Centricity and ICER Influence Payer Decisions?
The 21st Century Cures Act, as well as FDA guidelines, are putting a spotlight on patient centricity—from drug development to [...]
NBER Releases Cost-Sharing Report: Drug Price Increases Associated With Increased Mortality
The National Bureau of Economic Research (NBER) has released a report on how cost-sharing affects patient care. The authors found [...]
Understanding the Impact of COVID-19 on SDoH
COVID-19 has wreaked havoc across countless sectors and populations and has also deepened the social determinant risk. A new eBook [...]
Report on Impact of COVID-19 on Global Bioinformatics Market
A recent report discusses how COVID-19 affected the Bioinformatics Market. The impacts on five currencies (USD, EUR, AUD, GBP, JPY) [...]
Prediction Models for COVID-19 Can’t Account for All Human Elements
Early in the COVID-19 pandemic, researchers were scrambling to predict how the disease would spread. One such model was developed [...]
Meta-Analysis Study on Kidney Cancer Utilizes Novel Techniques to Identify Biomarkers
The survival rates of patients with kidney cancer largely depend on identifying biomarkers. The identification of these biomarkers can help [...]
Webinar on RWE and Progress During COVID-19 Pandemic
The COVID-19 Pandemic has driven many researchers to incorporate RWE (real world evidence) into clinical trials. However, it can often [...]
Outcry Over Nick Jonas in Super Bowl Commercial for Dexcom
Type 1 Diabetics typically check their blood glucose levels by pricking their finger with a needle to obtain a small [...]
Growing Support for HTA in Light of High Gene Therapy Costs
An independent review board, such as ICER, responsible for assessing appropriate costs for therapies and drugs has been discussed for [...]
ICER Releases Draft Evidence Report for Several Multiple Myeloma Therapies: Will These Drugs Prevent Relapse?
ICER has released a report on three therapies for multiple myeloma: belantamab mafodotin blmf from Blenrep™ and GlaxoSmithKline, idecabtagene vicleucel [...]
Matthew McHugh Appointed Director for Health Outcomes and Policy Research
Matthew McHugh is taking on a new role as Director for Health Outcomes and Policy Research (CHOPR) at the University [...]
Cytel Whitepaper Notes Changes in Clinical Trial Design
Advances in computation tools have forever changed clinical trial design and analysis. According to Nobel Prize winning behavioral economists Daniel [...]
[Whitepaper] Caring for Polychronic Patients
Patients with more than a single chronic disease require a different type of care. Understanding the challenges of this patient [...]
Value-Based Pricing For Treatments And Vaccines In The Context of COVID-19
Referencing ICER’s white paper and webinar series on the same topic, researchers at Tufts' Center for the Evaluation of Value and [...]
How Can Payers Advance Patient-reported Measures in Oncology?
A newly published study explored patient-reported performance measures in oncology, the barriers to implementation, and actionable recommendations for public and [...]
Achieving Accurate Estimates of Shared Savings from Value-based Healthcare
This article is part of a series focused on calculating shared savings from value-based health care improvement solutions. There is [...]
Value-based Care at Risk
An April survey by the National Association of ACOs showed that more than half the organizations in at-risk models planned [...]
How Should Value-based Care Be Implemented?
Value-based care is already proven to work, so the question now is how to best implement it. One possibility would [...]